tradingkey.logo
tradingkey.logo
Search

Armata Pharmaceuticals Inc

ARMP
Add to Watchlist
4.720USD
+0.040+0.85%
Close 08-05 16:00ETQuotes delayed by 15 min
172.96MMarket Cap
LossP/E TTM

ARMP Financials

See Armata Pharmaceuticals Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Armata Pharmaceuticals Inc Earnings Date

Latest Release
May 13, 2026
EPS / Forecast
-3.16/-0.38
Revenue / Forecast
789.00K/0.00
Period
FY2025 Earnings
Revenue(YoY)
4.90M
-5.22%
EPS(YoY)
-4.80
-816.80%
Analyst Rating
BUY
2026/08/05
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
Financial Indicators
EPS
-1649.43%-3.16
-4858.27%-3.42
-386.07%-0.74
-281.15%-0.45
73.94%-0.18
113.07%0.07
82.46%-0.15
352.74%0.25
-72.29%-0.69
-92.23%-0.55
---0.86
---0.10
---0.40
---0.29
---0.79
----
----
----
----
----
Revenue
60.69%789.00K
-12.15%1.08M
-61.02%1.16M
--2.17M
-49.17%491.00K
-19.18%1.23M
142.69%2.97M
-100.00%0.00
21.36%966.00K
45.39%1.53M
-8.45%1.23M
-47.96%980.00K
-35.60%796.00K
6.27%1.05M
6.95%1.34M
61.22%1.88M
15.95%1.24M
96.23%989.00K
334.38%1.25M
3667.74%1.17M
Net Profit
-1666.13%-115.35M
-4880.69%-124.30M
-386.68%-26.68M
-281.34%-16.30M
73.90%-6.53M
113.10%2.60M
82.41%-5.48M
353.34%8.99M
-72.68%-25.02M
-92.43%-19.85M
-261.75%-31.16M
61.51%-3.55M
-65.15%-14.49M
-70.56%-10.31M
-58.96%-8.61M
-48.77%-9.21M
-59.67%-8.77M
8.71%-6.05M
6.07%-5.42M
-31.51%-6.19M
Net Margin
-999.08%-14619.26%
-5541.62%-11456.04%
-1148.41%-2301.55%
---751.27%
48.65%-1330.14%
116.21%210.53%
92.75%-184.36%
----
-42.29%-2590.17%
-32.36%-1298.89%
---2543.76%
---361.94%
---1820.35%
---981.35%
---596.88%
----
----
----
----
----
Gross Margin
0.00%100.00%
0.00%100.00%
0.00%100.00%
--100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
----
0.00%100.00%
0.00%100.00%
--100.00%
--100.00%
--100.00%
--100.00%
--100.00%
----
----
----
----
----
Debt to assets ratio
317.02%491.26%
206.02%334.18%
49.51%163.46%
35.21%139.05%
7.38%117.80%
30.50%109.20%
71.17%109.33%
294.98%102.84%
268.46%109.70%
--83.68%
--63.87%
--26.04%
--29.77%
----
----
----
----
----
----
----
Revenue
60.69%789.00K
-12.15%1.08M
-61.02%1.16M
--2.17M
-49.17%491.00K
-19.18%1.23M
142.69%2.97M
-100.00%0.00
21.36%966.00K
45.39%1.53M
-8.45%1.23M
-47.96%980.00K
-35.60%796.00K
6.27%1.05M
6.95%1.34M
61.22%1.88M
15.95%1.24M
96.23%989.00K
334.38%1.25M
3667.74%1.17M
Operating profit
-7.25%-8.79M
20.19%-8.41M
20.30%-7.78M
42.55%-6.84M
19.92%-8.19M
-10.02%-10.54M
5.61%-9.76M
-23.73%-11.91M
9.85%-10.23M
7.25%-9.58M
-19.87%-10.34M
-4.44%-9.63M
-29.30%-11.35M
-70.77%-10.33M
-40.37%-8.62M
-48.81%-9.22M
-61.45%-8.78M
-12.98%-6.05M
-9.25%-6.14M
-34.99%-6.20M
Net Profit
-1666.13%-115.35M
-4880.69%-124.30M
-386.68%-26.68M
-281.34%-16.30M
73.90%-6.53M
113.10%2.60M
82.41%-5.48M
353.34%8.99M
-72.68%-25.02M
-92.43%-19.85M
-261.75%-31.16M
61.51%-3.55M
-65.15%-14.49M
-70.56%-10.31M
-58.96%-8.61M
-48.77%-9.21M
-59.67%-8.77M
8.71%-6.05M
6.07%-5.42M
-31.51%-6.19M
Current assets
-54.84%5.95M
-5.66%10.67M
-24.38%16.93M
-75.67%7.52M
-68.44%13.17M
-40.95%11.31M
-38.80%22.39M
15.16%30.90M
8.09%41.72M
-29.19%19.15M
10.05%36.59M
-35.04%26.83M
-20.75%38.59M
80.37%27.05M
134.48%33.24M
109.58%41.31M
102.58%48.70M
38.25%14.99M
-16.72%14.18M
-4.71%19.71M
Total current liabilities
-91.65%9.23M
-81.46%8.95M
18.40%139.95M
-2.51%120.08M
0.45%110.54M
193.11%48.25M
440.14%118.20M
138.90%123.18M
114.03%110.05M
-33.82%16.46M
212.45%21.88M
598.39%51.56M
725.81%51.41M
416.68%24.87M
33.31%7.00M
25.07%7.38M
24.99%6.23M
-28.20%4.81M
-25.69%5.25M
13.37%5.90M
Total assets
-20.00%69.80M
-11.05%76.88M
-8.88%89.52M
-25.41%80.79M
-27.51%87.25M
-12.12%86.44M
-12.88%98.24M
7.02%108.31M
10.64%120.36M
2.64%98.36M
21.40%112.76M
0.23%101.21M
0.94%108.78M
37.36%95.83M
117.67%92.88M
109.16%100.98M
103.93%107.77M
76.56%69.77M
-6.58%42.67M
-2.39%48.28M
Total liabilities
170.42%381.39M
119.76%295.48M
24.06%185.10M
-2.67%150.29M
-20.26%141.03M
3.09%134.46M
19.23%149.21M
88.15%154.41M
104.87%176.87M
118.27%130.43M
164.56%125.15M
72.08%82.07M
86.76%86.33M
34.67%59.75M
150.07%47.30M
142.56%47.69M
145.45%46.23M
114.78%44.37M
-10.16%18.92M
-0.81%19.66M
Total equity
-479.34%-311.59M
-355.23%-218.60M
-87.53%-95.59M
-50.76%-69.50M
4.83%-53.78M
-49.76%-48.02M
-311.54%-50.97M
-340.82%-46.10M
-351.75%-56.51M
-188.87%-32.06M
-127.18%-12.39M
-64.08%19.14M
-63.52%22.45M
42.06%36.08M
91.86%45.58M
86.21%53.29M
80.93%61.54M
34.68%25.40M
-3.51%23.75M
-3.44%28.62M
Net operating income
23.72%-5.78M
15.81%-6.67M
51.51%-4.30M
29.14%-7.21M
28.38%-7.58M
2.21%-7.93M
8.51%-8.86M
15.61%-10.18M
39.76%-10.58M
22.69%-8.11M
6.25%-9.69M
-48.01%-12.06M
-399.86%-17.57M
-21.95%-10.48M
-108.16%-10.33M
-79.55%-8.15M
35.80%-3.52M
-36.43%-8.60M
-27.94%-4.96M
-17.69%-4.54M
Net investment
36.36%-63.00K
-167.53%-52.00K
28.82%-242.00K
89.09%-149.00K
60.40%-99.00K
103.22%77.00K
90.32%-340.00K
-515.32%-1.37M
87.56%-250.00K
-625.27%-2.39M
-171.41%-3.51M
80.46%-222.00K
-751.69%-2.01M
299.56%455.00K
-122.34%-1.29M
-479.59%-1.14M
20.81%-236.00K
37.70%-228.00K
-618.52%-582.00K
28.21%-196.00K
Net financing
-93.58%641.00K
--658.00K
24637.70%14.97M
-100.00%0.00
-71.41%9.99M
100.00%0.00
-100.25%-61.00K
123.91%88.00K
18.03%34.93M
91.40%-43.00K
79916.13%24.80M
-152.05%-368.00K
-33.69%29.59M
-107.10%-500.00K
-63.95%31.00K
21.08%-146.00K
140.22%44.63M
1529.17%7.04M
43.33%86.00K
-160.46%-185.00K

FAQs

What is the total revenue of Armata Pharmaceuticals Inc?

According to Armata Pharmaceuticals Inc's FY2025 earnings report, its total revenue reached 4.90M, with a year-on-year change of 5.17M.

What are the current assets of Armata Pharmaceuticals Inc?

According to Armata Pharmaceuticals Inc's FY2025 earnings report, its current assets were 10.67M, with a year-on-year change of -5.66.

What are the total assets of Armata Pharmaceuticals Inc?

According to Armata Pharmaceuticals Inc's FY2025 earnings report, its total assets of Armata Pharmaceuticals Inc were 76.88M, with a year-on-year change of -11.05.

What are the total liabilities of Armata Pharmaceuticals Inc?

According to Armata Pharmaceuticals Inc's FY2025 earnings report, its total liabilities of Armata Pharmaceuticals Inc were 295.48M, with a year-on-year change of 119.76.

What is the total equity of Armata Pharmaceuticals Inc?

According to Armata Pharmaceuticals Inc's FY2025 earnings report, its total equity of Armata Pharmaceuticals Inc was -218.60M, with a year-on-year change of -355.23.

What is the net operating income of Armata Pharmaceuticals Inc?

According to Armata Pharmaceuticals Inc's FY2025 earnings report, its net operating income of Armata Pharmaceuticals Inc was -31.22M, with a year-on-year change of 26.43.

What is the net investment of Armata Pharmaceuticals Inc?

According to Armata Pharmaceuticals Inc's FY2025 earnings report, its net investment of Armata Pharmaceuticals Inc was -542.00K, with a year-on-year change of 71.15.

What is the net financing of Armata Pharmaceuticals Inc?

According to Armata Pharmaceuticals Inc's FY2025 earnings report, its net financing of Armata Pharmaceuticals Inc was 25.61M, with a year-on-year change of -26.73.

What is the Earnings Per Share (EPS) of Armata Pharmaceuticals Inc?

According to Armata Pharmaceuticals Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -4.80, with a year-on-year change of -816.80.

What is the net income of Armata Pharmaceuticals Inc?

According to Armata Pharmaceuticals Inc's FY2025 earnings report, its net income was -173.80M, with a year-on-year change of -818.79.

What is the net margin of Armata Pharmaceuticals Inc?

According to Armata Pharmaceuticals Inc's FY2025 earnings report, its net profit margin was -3544.03, with a year-on-year change of -869.38.

What is the debt-to-asset ratio of Armata Pharmaceuticals Inc?

According to Armata Pharmaceuticals Inc's FY2025 earnings report, its debt-to-asset ratio was 334.18, with a year-on-year change of 206.02.

What is the Return on Assets (ROA) of Armata Pharmaceuticals Inc?

According to Armata Pharmaceuticals Inc's FY2025 earnings report, its Return on Assets (ROA) was -212.83, with a year-on-year change of -939.64.

What is the operating profit of Armata Pharmaceuticals Inc?

According to Armata Pharmaceuticals Inc's FY2025 earnings report, its operating profit was -31.22M, with a year-on-year change of 26.43.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.